Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below.
This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in the number of products available for health care providers to use. In this podcast, faculty member Joshua Zeichner, MD, describes these 2 classes of agents and their uses, alone and in combination. He does this by answering questions that are frequently asked by dermatology health care professionals. 
Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Galderma.
Target Audience 
This activity will be specifically targeted to health care providers (HCPs) who manage neuromodulators and dermal fillers, including dermatologists, aestheticians, nurse practitioners, physician assistants, and registered nurses. Other HCPs involved in the management of facial aesthetics are also invited to participate. 
Learning Objectives
Upon successful completion of this activity, you should be better prepared to: 
· Describe the appropriate use of currently available neuromodulators and dermal fillers for the treatment of facial aging
· Identify patients who could benefit from a combined treatment approach or novel cosmetic injectable
Faculty:
Joshua Zeichner, MD
Director of Cosmetic and Clinical Research
Dermatology Department
Mount Sinai Hospital
Associate Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Disclosures: Grant/Research Support: AbbVie, Arcutis, ASLAN, Biofrontera, EPI Health, Galderma, Johnson & Johnson, L’Oréal, Procter & Gamble, Unilever; Consultant: AbbVie, Dermavant, Incyte, Leo Pharma, Pfizer, Sun Pharmaceutical Industries.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Release Date: February 15, 2023 
Expiration Date:  February 15, 2024
To claim credit, visit: https://gotoper.com/fclndf23